Large-scale testing (Phase 3)Study completedNCT00415597What this trial is testingStudy of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant PainWho this might be right forPain Pfizer 467
Large-scale testing (Phase 3)Study completedNCT00195728What this trial is testingLong Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant PainWho this might be right forModerate to Severe Chronic, Non-malignant Pain Abbott 431
Large-scale testing (Phase 3)Study completedNCT00412152What this trial is testingOxycodone-naloxone in Relieving Opioid-related ConstipationWho this might be right forPain Mundipharma Research GmbH & Co KG
Large-scale testing (Phase 3)Study completedNCT00412100What this trial is testingOxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related ConstipationWho this might be right forPain Mundipharma Research GmbH & Co KG
Large-scale testing (Phase 3)Study completedNCT01400139What this trial is testingLong-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.Who this might be right forChronic Nonmalignant and Nonneuropathic Pain Purdue Pharma LP 922
Large-scale testing (Phase 3)Study completedNCT00902837What this trial is testingOXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA SubjectsWho this might be right forChronic Osteoarthritis Mundipharma Research GmbH & Co KG 181
Large-scale testing (Phase 3)Study completedNCT01971632What this trial is testingA Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant PainWho this might be right forSubjects With Moderate to Severe, Chronic Nonmalignant Pain Mundipharma Research GmbH & Co KG 463